Viewing Study NCT00925015

Bugs

Ignite Creation Date: 2025-12-18 @ 8:22 AM

Ignite Modification Date: 2025-12-18 @ 8:22 AM

Study NCT ID: NCT00925015

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module